# Neurocrine Biosciences Inc: Form 8-K, filed Aug 28, 2024

- Company: [Neurocrine Biosciences Inc](/companies/nbix.md) (CIK 914475)
- Form: 8-K
- Filed: 2024-08-28
- Accepted by EDGAR: Aug 28, 2024, 07:00 ET
- Period: 2024-08-28
- Accession: 0000914475-24-000199
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/914475/000091447524000199/nbix-20240828.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/914475/000091447524000199/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/914475/000091447524000199/nbix-20240828.htm

Filed Aug 28, 2024.
Source: SEC EDGAR, the filing index for accession 0000914475-24-000199. Last ingested by Listed: Nov 5, 2026, 17:26 ET. No prices; not investment advice.